FAS agreed on the price limit for the COVID-19 medicine Kovidolek

The Federal Antimonopoly Service agreed on the maximum selling price of the drug for coronavirus infection "Kovidolek". This was reported in the Telegram channel of the service.

“The price for a pack of 40 tablets of 200 mg will be 2916 rubles,” the report says.

The FAS clarified that Kovidolek is an antiviral drug that is used in the treatment of COVID-19 . The drug is also included in the list of vital and essential drugs (VED).

The manufacturer of the drug is the pharmaceutical company Nanolek. In March of this year, the Russian Ministry of Health approved the conduct of the third phase of clinical trials of Covidolec (Favipiravir). The clinical trials are scheduled to end on December 31, 2022.